Compare ACCO & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACCO | SGHT |
|---|---|---|
| Founded | 1893 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Publishing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 353.3M | 309.6M |
| IPO Year | 2005 | 2021 |
| Metric | ACCO | SGHT |
|---|---|---|
| Price | $4.24 | $8.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $5.00 | ★ $9.08 |
| AVG Volume (30 Days) | ★ 626.2K | 262.8K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 9.26% | N/A |
| EPS Growth | ★ 141.51 | 28.16 |
| EPS | ★ 0.35 | N/A |
| Revenue | ★ $1,524,700,000.00 | $77,363,000.00 |
| Revenue This Year | $3.10 | $11.67 |
| Revenue Next Year | $0.89 | $10.39 |
| P/E Ratio | $12.09 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.81 | $3.19 |
| 52 Week High | $4.56 | $9.24 |
| Indicator | ACCO | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 74.99 |
| Support Level | $4.22 | $8.00 |
| Resistance Level | $4.33 | $8.93 |
| Average True Range (ATR) | 0.11 | 0.53 |
| MACD | -0.02 | 0.10 |
| Stochastic Oscillator | 18.64 | 84.72 |
ACCO Brands Corp is a consumer, technology and business branded products company providing brands and product solutions used in schools, homes and at work. Its brands include At-A-Glance, Barrilito, Buro, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Mead, PowerA, Quartet, Rapid, Swingline and Tilibra. The Company's product categories include gaming and computer accessories, storage and organization, notebooks, shredding, laminating and binding machines, dry erase boards and do-it-yourself tools. The Company operates through two segments, Americas and International. Americas includes the U.S., Canada, Brazil, Mexico and Chile, and International includes EMEA, Australia, New Zealand and Asia. Its products are sold in the U.S., Europe, Australia, Canada, Brazil and Mexico.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.